Effect of meconium ileus on the clinical prognosis of patients with cystic fibrosis

The objective of the present study was to determine the possible prognostic factors which may explain the difference in the survival of patients with cystic fibrosis (CF) with and without meconium ileus. Over a period of 20 years, 127 patients with CF, whose diagnosis was confirmed by typical clinic...

Full description

Bibliographic Details
Main Authors: M.C.L.A. Oliveira, F.J.C. Reis, A.P.A.F. Monteiro, F.J. Penna
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2002-01-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2002000100005
id doaj-c455f9fbd4b5444996bd516497fc2fcb
record_format Article
spelling doaj-c455f9fbd4b5444996bd516497fc2fcb2020-11-25T00:39:11ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2002-01-01351313810.1590/S0100-879X2002000100005Effect of meconium ileus on the clinical prognosis of patients with cystic fibrosisM.C.L.A. OliveiraF.J.C. ReisA.P.A.F. MonteiroF.J. PennaThe objective of the present study was to determine the possible prognostic factors which may explain the difference in the survival of patients with cystic fibrosis (CF) with and without meconium ileus. Over a period of 20 years, 127 patients with CF, whose diagnosis was confirmed by typical clinical characteristics and altered sweat chloride levels, were studied retrospectively. The patients were divided into two groups: group 1 consisted of patients who presented CF and meconium ileus (N = 9), and group 2 consisted of patients with CF without meconium ileus (N = 118). The characteristics studied were based on data obtained upon admission of the patients using a specific protocol. Demographic, clinical, nutritional and laboratory data were obtained. The genotype was determined in 106 patients by PCR. Survival was analyzed using the Kaplan-Meier method. The median follow-up period was 44 months. A statistically significant difference was observed between the groups studied regarding the following variables: age at diagnosis and weight and height z scores. The presence of meconium ileus was associated with an earlier diagnosis; these patients had greater deficits in height and weight at the time of diagnosis and at the end of the study. The estimated probability of survival for patients with CF without meconium ileus was 62 ± 14% and for those with meconium ileus 32 ± 18%. Patients with CF and meconium ileus presented a poor nutritional status at diagnosis and a lower survival rate compared to the general CF population.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2002000100005Cystic fibrosisMeconium ileusSurvivalNutritionGenotype
collection DOAJ
language English
format Article
sources DOAJ
author M.C.L.A. Oliveira
F.J.C. Reis
A.P.A.F. Monteiro
F.J. Penna
spellingShingle M.C.L.A. Oliveira
F.J.C. Reis
A.P.A.F. Monteiro
F.J. Penna
Effect of meconium ileus on the clinical prognosis of patients with cystic fibrosis
Brazilian Journal of Medical and Biological Research
Cystic fibrosis
Meconium ileus
Survival
Nutrition
Genotype
author_facet M.C.L.A. Oliveira
F.J.C. Reis
A.P.A.F. Monteiro
F.J. Penna
author_sort M.C.L.A. Oliveira
title Effect of meconium ileus on the clinical prognosis of patients with cystic fibrosis
title_short Effect of meconium ileus on the clinical prognosis of patients with cystic fibrosis
title_full Effect of meconium ileus on the clinical prognosis of patients with cystic fibrosis
title_fullStr Effect of meconium ileus on the clinical prognosis of patients with cystic fibrosis
title_full_unstemmed Effect of meconium ileus on the clinical prognosis of patients with cystic fibrosis
title_sort effect of meconium ileus on the clinical prognosis of patients with cystic fibrosis
publisher Associação Brasileira de Divulgação Científica
series Brazilian Journal of Medical and Biological Research
issn 0100-879X
1414-431X
publishDate 2002-01-01
description The objective of the present study was to determine the possible prognostic factors which may explain the difference in the survival of patients with cystic fibrosis (CF) with and without meconium ileus. Over a period of 20 years, 127 patients with CF, whose diagnosis was confirmed by typical clinical characteristics and altered sweat chloride levels, were studied retrospectively. The patients were divided into two groups: group 1 consisted of patients who presented CF and meconium ileus (N = 9), and group 2 consisted of patients with CF without meconium ileus (N = 118). The characteristics studied were based on data obtained upon admission of the patients using a specific protocol. Demographic, clinical, nutritional and laboratory data were obtained. The genotype was determined in 106 patients by PCR. Survival was analyzed using the Kaplan-Meier method. The median follow-up period was 44 months. A statistically significant difference was observed between the groups studied regarding the following variables: age at diagnosis and weight and height z scores. The presence of meconium ileus was associated with an earlier diagnosis; these patients had greater deficits in height and weight at the time of diagnosis and at the end of the study. The estimated probability of survival for patients with CF without meconium ileus was 62 ± 14% and for those with meconium ileus 32 ± 18%. Patients with CF and meconium ileus presented a poor nutritional status at diagnosis and a lower survival rate compared to the general CF population.
topic Cystic fibrosis
Meconium ileus
Survival
Nutrition
Genotype
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2002000100005
work_keys_str_mv AT mclaoliveira effectofmeconiumileusontheclinicalprognosisofpatientswithcysticfibrosis
AT fjcreis effectofmeconiumileusontheclinicalprognosisofpatientswithcysticfibrosis
AT apafmonteiro effectofmeconiumileusontheclinicalprognosisofpatientswithcysticfibrosis
AT fjpenna effectofmeconiumileusontheclinicalprognosisofpatientswithcysticfibrosis
_version_ 1725294661821530112